US Generic Drugs from History to the Future

💊 US Generic Drugs from History to the Future

A RxConnectIL Educational Session featuring speaker Adi Kleiman from CooperSurgical

🔬 About the Session

Generic medications form the very foundation of accessible healthcare in America — accounting for 90% of all prescriptions dispensed and generating a staggering $445 billion in annual savings for patients and healthcare payers alike.

This engaging session will take attendees on a journey through:

• 📜 Legislative milestones — including how the landmark 1984 Hatch-Waxman Act fundamentally reshaped the pharmaceutical industry
• 🏛️ The FDA regulatory pathway — a deep dive into the Abbreviated New Drug Application (ANDA) process
• 🔗 Supply chain dynamics — how complex networks influence drug pricing and product availability
• ⚠️ Current industry challenges — from supply chain vulnerabilities to growing market consolidation
• 🚀 Emerging trends — the exciting frontier of complex generics and biosimilars and what they mean for the future of affordable medication access

🎤 About the Speaker — Adi Kleiman

Adi brings over 20 years of experience in the pharmaceutical industry, with deep expertise in production and supply chain management. With more than 15 years specifically in the generics sector, Adi has spearheaded initiatives spanning everything from new product identification all the way through to successful market launches.

🎟️ Registration & Details

📍 Location: Register to receive the address
💸 Donation: Optional

👉 Register here

We look forward to seeing you there!
— Galit, Michal & Adi